<?xml version="1.0" encoding="UTF-8"?>
<ref id="B179">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sacramento</surname>
    <given-names>C. Q.</given-names>
   </name>
   <name>
    <surname>de Melo</surname>
    <given-names>G. R.</given-names>
   </name>
   <name>
    <surname>de Freitas</surname>
    <given-names>C. S.</given-names>
   </name>
   <name>
    <surname>Rocha</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Hoelz</surname>
    <given-names>L. V.</given-names>
   </name>
   <name>
    <surname>Miranda</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2017</year>). 
  <article-title>The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication</article-title>. 
  <source>Sci. Rep.</source>
  <volume>7</volume>:
  <fpage>40920</fpage>
  <pub-id pub-id-type="doi">10.1038/srep40920</pub-id>
  <pub-id pub-id-type="pmid">28098253</pub-id>
 </mixed-citation>
</ref>
